REG - Venture Life Group - Result of General Meeting

Venture LifeAnnouncement

05/08/2025 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250805:nRSE0926Ua&default-theme=true

RNS Number : 0926U  Venture Life Group PLC  05 August 2025

5 August 2025

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Company")

Result of General Meeting

Venture Life (AIM: VLG), a leader in developing, manufacturing and
commercialising products for the international self-care market, announces
that at the General Meeting ("GM") of the Company held at 10.00am today, both
resolutions proposed at the meeting were duly passed by shareholders.

The full proxy results of the AGM will shortly be provided in the Investor
Relations section of the Company's

website at   www.venture-life.com (http://www.venture-life.com)

 

For further information, please contact:

 

 Venture Life Group PLC                                    +44 (0) 1344 578004
 Jerry Randall, Chief Executive Officer

 Daniel Wells, Chief Financial Officer

 Cavendish Capital Markets Limited (Nomad and Broker)      +44 (0) 20 7720 0500
 Stephen Keys / George Lawson (Corporate Finance)

 Michael Johnson (Sales)

About Venture Life (www.venture-life.com (http://www.venture-life.com/) )

Venture Life is an international consumer self-care company focused on
commercialising products for the global self-care market. Headquartered in the
UK, the Group's product portfolio includes Balance Activ in the area of
women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel
product ranges for energy and glucose management and hypoglycaemia, the Health
and Her product range supporting the hormonal lifecycle, the UltraDEX and
Dentyl oral care product ranges. The products, which are typically recommended
by pharmacists or healthcare practitioners, are available primarily through
pharmacies and grocery multiples and are sold in over 90 countries worldwide.
In the UK, Ireland and the US these are supplied direct by the company to
retailers, elsewhere they are supplied by the Group's international
distribution partners.

 

LEI: 213800S8CZUPLAB2KC70

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSFFLIEISELA